TomaszStryjewskiMD

Cataract Related, Neuro-Ophthalmology, Retinal Disease

Eye Trauma Service Director

Dr. Stryjewski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
243 Charles St
Boston, MA 02114
Phone+1 617-573-3288

Fax+1 978-689-0731

Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 2014 - 2017
Massachusetts General HospitalResidency, Internal Medicine, 2013 - 2016
Harvard Medical SchoolClass of 2013

PubMed

Targeting the Tie-2 Receptor With Faricimab in Central Serous Chorioretinopathy: A Case Series Motivated by a Genetic Finding.
Joel T Rämö, Leo A Kim, Tomasz Stryjewski, Priya P Shah, Romy Bejjani
American Journal of Ophthalmology. 2025-01-01
Visual Outcomes and Risk of Endophthalmitis in Open Globe Injuries without Intraocular Foreign Bodies with Delayed Repair.
Marisa G Tieger, Nakul Singh, Racquel Bitar, Kevin Makhoul, Helia Ashourizadeh
Ophthalmology. 2024-12-01
1 citations
ENDOGENOUS ENDOPHTHALMITIS DUE TO STREPTOCOCCUS ANGINOSUS IN A HEALTHY, YOUNG WOMAN.
Jonathan B Lin, Dean Eliott, Lucia Sobrin, Tomasz P Stryjewski
Retinal Cases & Brief Reports. 2023-09-01

New Approaches to Securing Retinal Breaks During SurgeryNovember 1st, 2022
SUBSPECIALTY NEWS: Gene Therapy, Stem-Cell Therapy, DR Screening Rates for the Uninsured, and MoreApril 1st, 2019
Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio VisionJanuary 29th, 2019